Translational public health care perspective: intravitreal treatment of neovascular age-related macular degeneration has revolutionized clinical ophthalmology

Free article

Editorial

Sara Brandi Bloch et al. Acta Ophthalmol. 2015 Mar.

Free article

. 2015 Mar;93(2):103-4.

doi: 10.1111/aos.12680.

No abstract available

Comment on

Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting.
Hasler PW, Bloch SB, Villumsen J, Fuchs J, Lund-Andersen H, Larsen M. Hasler PW, et al. Acta Ophthalmol. 2015 Mar;93(2):122-5. doi: 10.1111/aos.12589. Epub 2014 Nov 17. Acta Ophthalmol. 2015. PMID: 25403735
A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration.
van Asten F, Evers-Birkenkamp KU, van Lith-Verhoeven JJ, de Jong-Hesse Y, Hoppenreijs VP, Hommersom RF, Scholten AM, Hoyng CB, Klaver JH; HELIOS study group. van Asten F, et al. Acta Ophthalmol. 2015 Mar;93(2):126-33. doi: 10.1111/aos.12610. Epub 2014 Dec 9. Acta Ophthalmol. 2015. PMID: 25488348